Linden Promotes Mark Sullivan to Partner
Chicago, Illinois (January 4, 2018) – Linden Capital Partners, a Chicago-based private equity firm focused exclusively on healthcare, today announced that Mark Sullivan has been promoted to Partner. Mr. Sullivan joined Linden in 2012 to lead the human capital and resource efforts. In addition to managing the internal human capital function, Mr. Sullivan leads the recruitment of Operating Partners, executive management, and members of boards of directors for Linden’s current and future portfolio companies. For Linden portfolio companies, he also closely collaborates with the boards and CEOs to monitor and execute on key strategic initiatives across the human capital function.
“For more than a decade, Linden has focused on human capital as a competitive advantage in private equity,” said Linden President and Managing Partner Tony Davis. “With Mark’s leadership, we institutionalized our approach of leveraging pre-eminent operators, boards of directors, and human capital best practices to drive returns for our investors. We will continue to invest in our efforts to emphasize our market-leading human capital strategy.”
Mr. Sullivan has spent the last twenty years in both finance and human capital focused roles. Most recently, he was an executive at Children’s Healthcare of Atlanta, a large multi-hospital healthcare system, and worked in the executive search practice at Korn/Ferry International. Prior to Korn/Ferry, Mr. Sullivan worked for a Fortune 50 company in Mergers and Acquisitions and Strategic Financial Analysis as part of its Financial Leadership Program. Mr. Sullivan began his career in a proprietary trading division of Cargill, Inc. He holds a BA in Economics from College of the Holy Cross and an MBA in Finance from Vanderbilt University.
About Linden Capital Partners
Linden Capital Partners is a Chicago-based private equity firm focused exclusively on leveraged buyouts in the healthcare industry. Linden’s strategy is based upon three elements: i) healthcare specialization, ii) integrated private equity and operating expertise, and iii) strategic relationships with large corporations. Linden invests in middle market platforms in the medical products, specialty distribution, pharmaceutical, and services segments of healthcare. For more information, please visit www.lindenllc.com.